Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jun 30, 2025 | Oakmark Global Fund | 6.0% | - | 3626.T, ADS.DE, AHT.L, AKZA.AS, ALV.DE, BAYN.DE, BDX, BMW.DE, BNP.PA, BUD, COP, DSV.CO, FI, IQV, KDP, LBRDK, LLOY.L, MOH | financials, global, healthcare, industrials, Logistics, Trade Policy, value | President Trump's Liberation Day announcement led to significant market volatility with companies perceived as more impacted by tariffs falling meaningfully while others held up better. The fund used this volatility to trim positions that performed well and buy companies where the discount to intrinsic value widened significantly. | MOH KDP BNP.PA BMW.DE AHT.L ADS.DE BDX DSV.CO |
View |
| 2024 Q1 | Apr 19, 2024 | Andvari Associates | 0.0% | 20.3% | AMT, BUD, CSGP, IWM, MA, MO, SPY, WEA | dividends, Quality, rates, real estate, Tobacco, value | CoStar Group is investing $1 billion into Homes.com to compete against Zillow in residential real estate. The National Association of Realtors settlement could provide a tailwind by changing commission structures that favor Homes.com's seller-focused business model over buyer-focused portals. | MO WEA CSGP KPG.AX |
View |
| 2025 Q1 | Mar 31, 2025 | The Davenport Value & Income Fund | 3.8% | 3.8% | AVY, BAM, BMY, BRK.B, BUD, CMCSA, CVX, ELV, FDX, HP, HSY, JNJ, LHX, NEE, NSC, ORCL, PM, SNY, STZ, UPS | Buybacks, Consumer Staples, Defensive, dividends, healthcare, value | Sixteen of DVIPX's holdings raised their dividends during the quarter, led by double-digit percentage increases at Walmart, Brookfield Corp, and others. The average DVIPX constituent has raised its dividend 8% year-over-year, which exceeds the S&P 500's 6%. The Fund is both higher yielding and possesses higher dividend growth than the benchmarks. | View | |
| 2025 Q1 | Mar 31, 2025 | Dodge & Cox Stock Fund | 3.5% | 3.5% | AMZN, AVTR, BUD, CHTR, CVS, FDX, FI, GILD, GOOGL, JCI, MET, RTX, SCHW, SNY, WFC | contrarian, financials, healthcare, industrials, tariffs, value, volatility | The fund trades at only 14.1 times forward earnings compared to 20.9 times for the S&P 500, representing a significant discount to the broader market. The valuation disparity between value and growth stocks narrowed during the quarter, with value outperforming growth substantially. | View | |
| 2024 Q4 | Dec 31, 2024 | Artisan International Fund | - | 10.6% | 2579.T, 4091.T, AER, AI.PA, AMZN, AON, ARGX, AZN, BA.L, BUD, FLTR, LIN, MRO.L, NG.L, NVO, RHM.DE, SHOP, UCB.BR, UCG.MI | Biotechnology, Cloud, defense, Energy Transition, healthcare, Industrial Gases, international, value | Healthcare holdings delivered robust performance with UCB's Bimzelx approval for chronic inflammatory skin conditions adding $1.8 billion in peak sales potential. Argenx advanced VYVGART to phase 3 trials for myositis treatment, potentially adding $2 billion to peak sales. The VYVGART franchise grew 20% with total peak sales projected to exceed $10 billion. | View | |
| 2024 Q4 | Dec 31, 2024 | Dodge & Cox Stock Fund | -1.5% | 14.5% | AMZN, AVTR, BUD, CHTR, CVS, FDX, FI, GILD, GOOGL, JCI, MET, RTX, SCHW, SNY, WFC | contrarian, financials, healthcare, industrials, large cap, value | The fund trades at only 14.1 times forward earnings compared to 20.9 times for the S&P 500 and 17.2 times for the Russell 1000 Value. The valuation disparity between value and growth stocks narrowed during the quarter, with value outperforming growth substantially. | View | |
| 2024 Q2 | Jul 15, 2024 | Bengal Capital | 4.0% | 105.0% | BAMM, BUD, GDNSF, GRUSF, GTI, SAM, XSF.TO | Cannabis, Capital markets, growth, MSOs, undervalued, value | The fund focuses exclusively on cannabis investments, holding positions in Grown Rogue, XS Financial, Goodness Growth, and Body and Mind. The manager argues that cannabis is not truly high growth but rather rapid absorption of illicit markets by regulated markets, with consistent patterns of increased units and decreased prices. | View | |
| 2023 Q2 | Jun 30, 2023 | Oakmark Global Fund | 7.5% | 0.0% | AIG, AMZN, ARNC, BABA, BAC, BUD, CNHI, COP, CRBG, CWK, DHR, GLEN.L, GOOGL, IQV, MBG.DE, NOV, ORCL, RYAAY, THC | energy, global, insurance, Life Sciences, technology, value | The fund initiated positions in Danaher and IQVIA Holdings, both leaders in life sciences. Danaher maintains a portfolio focused on bioprocessing, life science tools, genomics and diagnostics with secular growth opportunities. IQVIA is positioned at the heart of trends toward advanced therapeutics and personalized medicine as the most levered CRO to decentralized clinical trials. | IQV DHR CRBG |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| David Hoeft | Dodge & Cox | $185.3B | $2.1B | 1.14% | 33,113,431 | -3,432,790 | -9.39% | 1.3815% |
| Tom Russo | Gardner Russo & Quinn | $9.3B | $17.1M | 0.18% | 265,525 | -16,690 | -5.91% | 0.0112% |
| Mark A. Hillman | Hillman Value Fund | $158.9M | $5.3M | 3.33% | 82,631 | -8,107 | -8.93% | 0.0034% |
| Sarah Ketterer | Causeway Capital Management LLC | $7.3B | $44.9M | 0.62% | 701,343 | +91,657 | +15.03% | 0.0293% |
| Paul Tudor Jones | Tudor Investment Corp | $53.4B | $6.8M | 0.01% | 105,760 | -25,898 | -19.67% | 0.0044% |
| Steven A. Cohen | Point72 Asset Management | $86.8B | $50.4M | 0.06% | 786,664 | -68,000 | -14.45% | 0.0328% |
| Lee Ainslie | Maverick Capital | $9.3B | $2.3M | 0.02% | 35,898 | +9,098 | +33.95% | 0.0015% |
| Dmitry Balyasny | Balyasny Asset Management | $76.6B | $8.0M | 0.01% | 125,000 | +50,000 | +66.67% | 0.0052% |
| Israel Englander | Millennium Management LLC | $233.2B | $30.8M | 0.01% | 481,664 | -400 | -0.79% | 0.0201% |
| Terrence Murphy | Clearbridge Investments | $124.9B | $6.6M | 0.01% | 102,594 | +320 | +0.31% | 0.0043% |
| David Siegel & John Overdeck | Two Sigma Investments | $67.5B | $2.8M | 0.00% | 44,200 | +15,300 | +52.94% | 0.0018% |
| Cliff Asness | AQR Capital Management | $190.6B | $4.0M | 0.00% | 62,014 | +35,989 | +138.29% | 0.0026% |
| Mario Gabelli | GAMCO Investors | $10.4B | $768,480 | 0.01% | 12,000 | -540 | -4.31% | 0.0005% |
| Bill Gates | Bill & Melinda Gates Foundation Trust | $35.4B | $109.1M | 0.31% | 1,703,000 | +0 | +0.00% | 0.0710% |
| Richard Kayne & John Anderson | Kayne Anderson Rudnick Investment Management | $37.3B | $567,936 | 0.00% | 8,868 | +472 | +5.62% | 0.0004% |